BIOPRO PROXIMAL FEMORAL ARTICULAR REPLACEMENT— 510(k) K894604

Name: FDA 510(k) clearance K894604
Creator: U.S. Food and Drug Administration
Published: 1989-11-17

Substantially Equivalent for Some Indications

Biopro, Inc.

FDA 510(k) clearance K894604 for BIOPRO PROXIMAL FEMORAL ARTICULAR REPLACEMENT, Substantially Equivalent for Some Indications on 1989-11-17. Applicant: Biopro, Inc.. Device class: 2.

Clearance details

Applicant: Biopro, Inc.
Product code: Code KXA
Device class: Class 2
Regulation: 21 CFR 888.3400
Advisory panel: Orthopedic
Date received: 1989-07-20
Decision date: 1989-11-17
Decision: Substantially Equivalent for Some Indications
Clearance type: Traditional
Location: Port Huron, MI, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KXA

view all

K201219 — Biocore9 Femoral Head Resurfacing Component2021-01-19
K092198 — CORMET CEMENTLESS RESURFACING FEMORAL HEAD2010-04-15
K082673 — CONSERVE PRESSFIT FEMORAL COMPONENT2008-12-12
K071053 — RECAP HA PRESS-FIT FEMORAL RESURFACING HEAD2007-06-29
K070292 — DUROM HIP RESURFACING SYSTEM, FEMORAL COMPONENTS2007-04-26

More clearances from Biopro, Inc.

view all

K163627 — Shotel Ankle Arthrodesis Nail System2017-09-14
K162674 — BioPro Foot Plating Systems2017-06-16
K132510 — BIOPRO - INFINITY PLATE ANCHOR SYSTEM2013-10-24
K130298 — BIOPRO KWICK-WIRE UNIVERSAL SCREW SYSTEM2013-06-18
K121973 — BIOPRO HEMI-EDGE TOE SYSTEM2012-10-30

Adverse events under product code KXA

product code KXA

Injury: 324
Total: 324

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.